Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia

Molybdenum Trioxide purified Antimony Trioxide extrapurified AR Molybdenum Trioxide extrapurified AR Pyridine-Sulfur Trioxide Complex Lead Titanium Trioxide Sulfur Trioxide Pyridine Complex

Acquired genetic mutations can confer resistance to arsenic trioxide (ATO) within the remedy of acute promyelocytic leukemia (APL). Nonetheless, such resistance-conferring mutations are uncommon and don’t clarify most illness recurrence seen within the clinic.
Now we have generated secure ATO-resistant promyelocytic cell strains which are additionally much less delicate to ATRA and the mix of ATO and ATRA in comparison with the delicate cell line.
Characterization of those in-house generated resistant cell strains confirmed important variations in immunophenotype, drug transporter expression, anti-apoptotic protein dependence, and PML-RARA mutation. Gene expression profiling revealed outstanding dysregulation of the mobile metabolic pathways in these ATO resistant APL cell strains.
Glycolytic inhibition by 2-DG was enough and corresponding to the usual of care (ATO) in focusing on the delicate APL cell line. 2-DG was additionally efficient within the in vivo transplantable APL mouse mannequin; nevertheless, it didn’t have an effect on the ATO resistant cell strains. In distinction, the resistant cell strains had been considerably affected by compounds focusing on the mitochondrial respiration when mixed with ATO, regardless of the ATO resistance-conferring genetic mutations or the sample of their anti-apoptotic protein dependency.
Our information exhibit that the addition of mitocans together with ATO can overcome ATO resistance. We additional present that this mixture has the potential within the remedy of non-M3 AML and relapsed APL. The interpretation of this strategy within the clinic must be explored additional.

Colorimetric Comparability of Inside Bleaching with and with out Eradicating Mineral Trioxide Mixture (MTA) on Induced Coronal Tooth Discoloration by MTA

This examine aimed to colorimetric comparability of inner bleaching with and with out eradicating mineral trioxide combination (MTA) on induced coronal tooth discoloration by MTA cement. On this experimental examine, twenty human tooth had been ready.
An OrthoMTA barrier was positioned 1 mm beneath the CEJ. The tooth had been restored with composite resin and had been positioned within the ageing accelerator machine. Then, the specimens had been divided into two teams (n = 10); in group A, a part of the OrthoMTA was eliminated and the glass ionomer was positioned on the OrthoMTA, and in group B, the OrthoMTA remained intact. Inside bleaching was carried out 5 instances in 6-day intervals utilizing 37% carbamide peroxide gel.
Coloration dedication was carried out in 5 phases: baseline, after OrthoMTA discoloration, earlier than OrthoMTA elimination, after OrthoMTA elimination, and after bleaching remedy periods. In group A, eight specimens reached to ∆E < 3.Three after 2 instances inner bleaching remedy, and in group B, 5 specimens reached to ∆E < 3.Three with nearly Three bleaching periods (p > 0.05).
Moreover, 5 specimens reached to the preliminary colour (baseline) after bleaching remedy, Four specimens in group A and 1 specimen in group B. After OrthoMTA elimination, 2 specimens in group A reached to ∆E < 3.3. There was no important distinction between teams with or with out OrthoMTA elimination (p=0.06). Though, the specimens with OrthoMTA elimination required fewer bleaching remedy periods, and the imply worth of ∆E was decrease on this group.
 Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
Iridium in Tungsten Trioxide Matrix as an Environment friendly Bi-Purposeful Electrocatalyst for General Water Splitting in Acidic Media
Electrocatalytic water splitting in acidic media is a promising technique for grid scale manufacturing of hydrogen utilizing renewable power, however challenges nonetheless exist within the growth of superior catalysts with each excessive exercise and stability.
Herein, it’s reported that iridium doped tungsten trioxide (Ir-doped WO3 ) with arrayed construction and confined Ir websites is an environment friendly and sturdy bi-functional catalyst for general acidic water splitting. A low overpotential (258 mV) is required to realize an oxygen evolution response present density of 10 mA cm-2 in 0.5 m H2 SO4 answer.
In the meantime, Ir-doped WO3 processes the same intrinsic exercise to Pt/C towards hydrogen evolution response. General water splitting utilizing the bi-functional Ir-doped WO3 catalyst exhibits low cell voltages of 1.56 and 1.68 V to drive the present densities of 10 and 100 mA cm-2 , respectively, with solely 16 mV decay noticed after 60 h steady electrolysis underneath the present density of 100 mA cm-2 . Structural evaluation and density useful idea calculation point out that the adjusted coordination setting of Ir inside the crystalline matrix of WO3 contributes to the excessive exercise and sturdiness.

Pulpal response to mineral trioxide combination containing phosphorylated pullulan-based capping materials

This examine aimed to judge the pulpal responses of monkey’s pulp after direct pulp capping (DPC) with the novel mineral trioxide combination containing phosphorylated pullulan-based materials (MTAPPL). Seventy-two tooth had been randomly divided into 4 teams: MTAPPL; Nex-Cem MTA (NX);
TheraCal LC (TH); and Dycal (DY). Histopathological adjustments within the pulps had been noticed at days 3, 7 and 70. On day 3, delicate inflammatory responses had been noticed within the MTAPPL, no to reasonable inflammatory responses within the TH, whereas reasonable inflammatory responses within the NX and DY. No mineralized tissue formation (MTF) was noticed in all teams.
On day 7, no or delicate inflammatory responses had been noticed in all teams. Preliminary MTF was noticed aside from DY. No irritation with full MTF together with presence of odontoblast-like cells was noticed within the MTAPPL, NX and TH teams at day 70. These findings point out that MTAPPL might be an environment friendly DPC materials.

Liquiritigenin protects towards arsenic trioxide-induced liver damage by inhibiting oxidative stress and enhancing mTOR-mediated autophagy

Liquiritigenin (LQ) has protecting results towards varied hepatotoxicities. Nonetheless, its particular position on arsenic trioxide (ATO)-induced hepatotoxicity and the associated biomolecular mechanisms stay unclear.
The aim of this examine is to discover the protecting actions of LQ on ATO-induced hepatotoxicity and its biomolecular mechanisms in mice. LQ was administered orally at 20 and 40 mg/kg per day for seven consecutive days with an intraperitoneal injection of ATO (5 mg/kg). Liver damage was induced by ATO and was alleviated by remedy with LQ as mirrored by diminished histopathological injury of liver and decreased serum ALT, AST, and ALP ranges.
The era of intracellular ROS induced by ATO was attenuated after LQ remedy. The degrees of SOD, CAT, and GSH had been elevated with LQ administration whereas MDA ranges decreased. LQ mitigated elevated TNF-α and IL-6 ranges in addition to the hepatic mitochondrial injury brought on by ATO. Furthermore, LQ upregulated the expression of LC3-II and enhanced autophagy within the liver of ATO-induced mice. Additional research indicated that LQ considerably suppressed the expression of p-PI3K, p-AKT, and p-mTOR in ATO-induced mice.

Molybdenum Cofactor Synthesis 2 Protein

20-abx263321
  • EUR 1609.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 2 µg
  • Shipped within 5-10 working days.

Molybdenum Cofactor Sulfurase (MOCOS) Antibody

abx235263-100ug 100 ug
EUR 481
  • Shipped within 5-12 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx005887
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx113871
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx036894-100ug 100 ug
EUR 391
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx037731-100ug 100 ug
EUR 391
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131326
  • EUR 439.00
  • EUR 133.00
  • EUR 1233.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131327
  • EUR 425.00
  • EUR 133.00
  • EUR 1205.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx135733
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321401
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321402
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx235264-100ug 100 ug
EUR 481
  • Shipped within 5-12 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx321947
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx322547
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx304514
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Hu01
  • EUR 503.20
  • EUR 238.00
  • EUR 1612.00
  • EUR 604.00
  • EUR 1108.00
  • EUR 400.00
  • EUR 3880.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Q9NZB8
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 21.5kDa
  • Isoelectric Point: Inquire
Description: Recombinant Human Molybdenum Cofactor Synthesis 1 expressed in: E.coli

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Mu01
  • EUR 458.40
  • EUR 226.00
  • EUR 1444.00
  • EUR 548.00
  • EUR 996.00
  • EUR 370.00
  • EUR 3460.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Q5RKZ7
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 22.4kDa
  • Isoelectric Point: Inquire
Description: Recombinant Mouse Molybdenum Cofactor Synthesis 1 expressed in: E.coli

Bovine MOCOS/ Molybdenum cofactor sulfurase ELISA Kit

E0183Bo 1 Kit
EUR 717

Human Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx250798-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Mouse Mocos/ Molybdenum cofactor sulfurase ELISA Kit

E0967Mo 1 Kit
EUR 632

ELISA kit for Human Molybdenum cofactor sulfurase

EK3232 96 tests
EUR 553
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Molybdenum cofactor sulfurase in samples from serum, plasma, tissue homogenates and other biological fluids.

Human MOCOS/ Molybdenum cofactor sulfurase ELISA Kit

E1626Hu 1 Kit
EUR 605

Human MOCOS(Molybdenum cofactor sulfurase) ELISA Kit

EH1514 96T
EUR 567.6
  • Detection range: 0.312-20 ng/ml
  • Uniprot ID: Q96EN8
  • Alias: MOCOS/Molybdenum cofactor sulfurase/MCS/MOS/MoCo sulfurase/hMCS/Molybdenum cofactor sulfurtransferase
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Mouse Molybdenum cofactor sulfurase, Mocos ELISA KIT

ELI-16543m 96 Tests
EUR 865

Bovine Molybdenum cofactor sulfurase, MOCOS ELISA KIT

ELI-19415b 96 Tests
EUR 928

Human Molybdenum cofactor sulfurase, MOCOS ELISA KIT

ELI-20833h 96 Tests
EUR 824

Human Molybdenum Cofactor Synthesis 1 (MOCS1) Protein

20-abx650079
  • EUR 704.00
  • EUR 286.00
  • EUR 2165.00
  • EUR 829.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Mouse Molybdenum Cofactor Synthesis 1 (MOCS1) Protein

20-abx650080
  • EUR 648.00
  • EUR 272.00
  • EUR 1943.00
  • EUR 759.00
  • EUR 467.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Cow Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx516487-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Mouse Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx516489-96tests 96 tests
EUR 739
  • Shipped within 5-12 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (HRP)

20-abx304515
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (FITC)

20-abx304516
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (Biotin)

20-abx304517
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Human Molybdenum Cofactor Synthesis 2 (MOCS2) ELISA Kit

abx381488-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human)

4-PAC623Hu01
  • EUR 247.00
  • EUR 2510.00
  • EUR 625.00
  • EUR 310.00
  • EUR 214.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1)

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse)

4-PAC623Mu01
  • EUR 251.00
  • EUR 2576.00
  • EUR 640.00
  • EUR 316.00
  • EUR 215.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1)

MOCS2 Molybdenum Cofactor Synthesis 2 Human Recombinant Protein

PROTO96033-1 Regular: 10ug
EUR 317
Description: MOCS2 Human Recombinant produced in E. coli is a single polypeptide chain containing 224 amino acids (1-188) and having a molecular mass of 25.0 kDa.;MOCS2 is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Purified GFP

AG45-0205-Z 0.1 mg
EUR 228

Ovalbumin, purified

O705084 1g
EUR 67.4
  • Product category: Proteins/Recombinant Proteins/Other

Mocos ELISA Kit| Mouse Molybdenum cofactor sulfurase ELISA Kit

EF015558 96 Tests
EUR 689

MOCOS ELISA Kit| Bovine Molybdenum cofactor sulfurase ELISA Kit

EF011614 96 Tests
EUR 689

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), APC

4-PAC623Hu01-APC
  • EUR 345.00
  • EUR 3275.00
  • EUR 912.00
  • EUR 440.00
  • EUR 219.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with APC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), Biotinylated

4-PAC623Hu01-Biotin
  • EUR 311.00
  • EUR 2460.00
  • EUR 727.00
  • EUR 381.00
  • EUR 219.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Biotin.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), Cy3

4-PAC623Hu01-Cy3
  • EUR 419.00
  • EUR 4325.00
  • EUR 1175.00
  • EUR 545.00
  • EUR 251.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Cy3.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), FITC

4-PAC623Hu01-FITC
  • EUR 296.00
  • EUR 2640.00
  • EUR 750.00
  • EUR 372.00
  • EUR 195.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with FITC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), HRP

4-PAC623Hu01-HRP
  • EUR 316.00
  • EUR 2855.00
  • EUR 807.00
  • EUR 398.00
  • EUR 206.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with HRP.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), PE

4-PAC623Hu01-PE
  • EUR 296.00
  • EUR 2640.00
  • EUR 750.00
  • EUR 372.00
  • EUR 195.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Met1~Leu160)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with PE.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), APC

4-PAC623Mu01-APC
  • EUR 351.00
  • EUR 3365.00
  • EUR 935.00
  • EUR 449.00
  • EUR 222.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with APC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), Biotinylated

4-PAC623Mu01-Biotin
  • EUR 316.00
  • EUR 2526.00
  • EUR 744.00
  • EUR 387.00
  • EUR 221.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Biotin.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), Cy3

4-PAC623Mu01-Cy3
  • EUR 427.00
  • EUR 4445.00
  • EUR 1205.00
  • EUR 557.00
  • EUR 254.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Cy3.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), FITC

4-PAC623Mu01-FITC
  • EUR 301.00
  • EUR 2712.00
  • EUR 768.00
  • EUR 379.00
  • EUR 197.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with FITC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), HRP

4-PAC623Mu01-HRP
  • EUR 321.00
  • EUR 2933.00
  • EUR 827.00
  • EUR 405.00
  • EUR 209.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with HRP.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), PE

4-PAC623Mu01-PE
  • EUR 301.00
  • EUR 2712.00
  • EUR 768.00
  • EUR 379.00
  • EUR 197.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: MOCS1 (Thr457~Ala636)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with PE.

Anti-Cytokeratins Purified

11-108-C025 0.025 mg
EUR 99

Anti-Cytokeratins Purified

11-108-C100 0.1 mg
EUR 158

Anti-MFG Purified

11-113-C025 0.025 mg
EUR 90

Anti-MFG Purified

11-113-C100 0.1 mg
EUR 140

Anti-p53 Purified

11-114-C025 0.025 mg
EUR 104

Anti-p53 Purified

11-114-C100 0.1 mg
EUR 167

Anti-CDK1 Purified

11-115-C025 0.025 mg
EUR 108

Anti-CDK1 Purified

11-115-C100 0.1 mg
EUR 177

Anti-hTSH Purified

11-124-C025 0.025 mg
EUR 90

Anti-hTSH Purified

11-124-C100 0.1 mg
EUR 140

Anti-hTSH Purified

11-125-C025 0.025 mg
EUR 90

Anti-hTSH Purified

11-125-C100 0.1 mg
EUR 140

Anti-hGH Purified

11-126-C025 0.025 mg
EUR 99

Anti-hGH Purified

11-126-C100 0.1 mg
EUR 158

Anti-Lactoferrin Purified

11-128-C025 0.025 mg
EUR 99

Anti-Lactoferrin Purified

11-128-C100 0.1 mg
EUR 158

Anti-Ikaros Purified

11-159-C025 0.025 mg
EUR 99

Anti-Ikaros Purified

11-159-C100 0.1 mg
EUR 158

Anti-PCNA Purified

11-182-C025 0.025 mg
EUR 99

Anti-PCNA Purified

11-182-C100 0.1 mg
EUR 158

Anti-NG2 Purified

11-199-C025 0.025 mg
EUR 99

Anti-NG2 Purified

11-199-C100 0.1 mg
EUR 158

Anti-Insulin Purified

11-246-C025 0.025 mg
EUR 99

Anti-Insulin Purified

11-246-C100 0.1 mg
EUR 158

Anti-MAP2 Purified

11-253-C025 0.025 mg
EUR 113

Anti-MAP2 Purified

11-253-C100 0.1 mg
EUR 186

Anti-Vimentin Purified

11-254-C025 0.025 mg
EUR 113

Anti-Vimentin Purified

11-254-C100 0.1 mg
EUR 186

Anti-GFAP Purified

11-255-C025 0.025 mg
EUR 113

Anti-GFAP Purified

11-255-C100 0.1 mg
EUR 186

Anti-Transferrin Purified

11-258-C025 0.025 mg
EUR 99

Anti-Transferrin Purified

11-258-C100 0.1 mg
EUR 158

Anti-HRP Purified

11-262-C025 0.025 mg
EUR 90

Anti-HRP Purified

11-262-C100 0.1 mg
EUR 140

Anti-Phosphotyrosine Purified

11-263-C025 0.025 mg
EUR 113

Anti-Phosphotyrosine Purified

11-263-C100 0.1 mg
EUR 186

Anti-LCK Purified

11-269-C025 0.025 mg
EUR 113

Anti-LCK Purified

11-269-C100 0.1 mg
EUR 186

Anti-BrdU Purified

11-286-C025 0.025 mg
EUR 108
In conclusion, our findings present that LQ protects towards ATO-induced hepatotoxicity as a consequence of its antioxidant and anti inflammatory actions and enhancement of autophagy mediated by the PI3K/AKT/mTOR signaling pathway in mice.

Leave a Reply

Your email address will not be published. Required fields are marked *